Professor Paolo Bidoli is a consultant oncologist at the Casa di Cura La Madonnina.
After graduating from the University of Pavia in 1981 with a degree in Medicine and Surgery, in 1987 he again received a specialization in internal medicine at the same university, and in 1991 in medical oncology at the University of Milan.
Associate Professor of Medical Oncology at the Bicocca University of Milan, he developed his professional career in high-profile structures such as the Clinica Medica of the University of Pavia, the Foundation of the IRCCS Nazionale dei Tumori in Milan (as an assistant in pulmonary pathology for more than 24 years, of which 15 under the leadership of Gianni Bonadonna and 9 as Deputy Director of the Department of Medical Oncology 2) as well as at the Ospedale San Gerardo in Monza, in which he was the Director of the Department of the Medical Area for 3 years and for more than 12 years Director of the Comprehensive Structure of Oncology, creating here is an oncology department, recognized as one of the first in the country in terms of the quality of medical care.
His work has always been focused on the most modern treatment programs and patient expectations regarding quality of life, giving preference, where possible, to so-called "precision medicine", immunotherapy programs and "individualized" chemotherapy in the "scope of various oncological pathologies, such as:
- neoplasms of the mediastinum and lungs, including mesothelioma
- neoplasms of the gastrointestinal tract
- breast cancer
- neoplasms of the urogenital tract.
The skills developed by the Professor include the management of various stages of cancer, including:
- quick organization and subsequent interpretation of diagnostic tests
- coordination of any interdisciplinary approaches
- personal management of appropriate medical therapy, without neglecting aspects of prevention for family members in case of genetic predisposition.
To this is added the possibility of compiling "second opinion reports" both (preferably) after a clinical assessment of the patient's subjective condition and the available clinical and radiological documentation, and remotely (after, obviously, evaluating the only radiological documentation and clinical reports).
For many years, Professor Bidoli has collaborated mainly as a "principal investigator" with national and international research groups, achieving the position of a "key leader of public opinion" in the context of various solid neoplasms and publishing in industry journals with a high impact factor.
His Hirsch Index is 29 (Scopus source) as of 31/12/20. He is the author or co-author of more than 100 articles in international indexed journals with a common IP address 319 (ISI WOS). He has participated in more than 300 national and international research projects related to phase 1, 2, 3 clinical trials. He is the author of the chapter "About Lung Neoplasms" VII, VIII, IX editions of the famous handbook of Oncological Medicine (G. Bonadonna, G. Robustelli Della Cuna and P. Valagussa Editori) ed. Elsevier – Masson, Miano. For several years, Professor Bidoli has been the compiler of guidelines on esophageal pathology for the Italian Association for Medical Oncology (AIOM), in which he currently serves as a "referent". Finally, this is supplemented by the activities of the coordinator, moderator and speaker of numerous seminars and scientific training courses, in particular on various therapeutic aspects of pathology of the lungs and gastrointestinal tract.